Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$127.80 /

-2.88 (-2.20%)

09:50
09/10/20
09/10
09:50
09/10/20
09:50

Sarepta filing for SRP-9001 could still meet expectations, says Piper Sandler

Piper Sandler analyst Tyler Van Buren has "minor concern" regarding the FDA's potency assay request after speaking with the management of Sarepta Therapeutics. While there is inherent uncertainty with FDA timelines, management is hopeful that this can get resolved within three-to-four months, Van Buren tells investors in a research note. If that occurs, Sarepta can begin the commercial supply study by early next and generate the 12-week dystrophin expression bridging data around the potentially registrational study 102 data, says the analyst. As such, he believes Sarepta could still file SRP-9001 for approval relatively in-line with current expectations. The analyst keeps an Overweight rating on the shares with a $200 price target.

  • 14

    Sep

  • 25

    Feb

SRPT Sarepta
$127.80 /

-2.88 (-2.20%)

09/10/20 Mizuho
Sarepta potential study delay 'largely immaterial,' says Mizuho
09/10/20 Goldman Sachs
Sarepta Phase 3 timelines 'could remain intact,' says Goldman Sachs
08/31/20 H.C. Wainwright
Sarepta price target lowered to $221 from $260 at H.C. Wainwright
08/25/20 JPMorgan
Sarepta added to Analyst Focus List, named a Top Idea at JPMorgan

TODAY'S FREE FLY STORIES

Hot Stocks
Plus Therapeutics expands ReSPECT trial to MD Anderson Cancer Center » 07:35
12/01/20
12/01
07:35
12/01/20
07:35
PSTV

Plus Therapeutics

$2.13 /

-0.01 (-0.47%)

Plus Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PSTV Plus Therapeutics
$2.13 /

-0.01 (-0.47%)

PSTV Plus Therapeutics
$2.13 /

-0.01 (-0.47%)

10/16/20
Fly Intel: Top five analyst initiations
10/16/20 Maxim
Plus Therapeutics initiated with a Buy at Maxim
PSTV Plus Therapeutics
$2.13 /

-0.01 (-0.47%)

Options
Unusual call flow in option market yesterday » 07:35
12/01/20
12/01
07:35
12/01/20
07:35
SNDL

Sundial Growers

$0.72 /

+0.347 (+93.28%)

, TCOM

Trip.com Group

$33.60 /

-0.62 (-1.81%)

, HZNP

Horizon Therapeutics

$70.20 /

-0.47 (-0.67%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNDL Sundial Growers
$0.72 /

+0.347 (+93.28%)

HZNP Horizon Therapeutics
$70.20 /

-0.47 (-0.67%)

SNDL Sundial Growers
$0.72 /

+0.347 (+93.28%)

08/17/20 CIBC
Sundial Growers upgraded to Neutral from Underperformer at CIBC
06/29/20 BMO Capital
Sundial Growers upgraded to Market Perform from Underperform at BMO Capital
04/02/20 BMO Capital
Sundial Growers downgraded to Underperform from Market Perform at BMO Capital
02/24/20 Cowen
Cowen cautious on Canada cannabis, downgrades Aurora, Sundial, Tilray
TCOM Trip.com Group
$33.60 /

-0.62 (-1.81%)

11/10/20 Credit Suisse
Trip.com Group upgraded to Outperform from Neutral at Credit Suisse
09/28/20 Barclays
Trip.com Group price target raised to $36 from $31 at Barclays
09/25/20 Mizuho
Trip.com Group price target raised to $33 from $29 at Mizuho
09/15/20
Fly Intel: Top analyst downgrades
HZNP Horizon Therapeutics
$70.20 /

-0.47 (-0.67%)

11/24/20 Benchmark
Halozyme price target raised to $46 from $39 at Benchmark
11/24/20 Benchmark
Halozyme price target raised to $46 from $39 at Benchmark
11/23/20 Piper Sandler
Halozyme price target raised to $42 from $37 at Piper Sandler
11/03/20 BMO Capital
Horizon Therapeutics price target raised to $110 from $105 at BMO Capital
TCOM Trip.com Group
$33.60 /

-0.62 (-1.81%)

HZNP Horizon Therapeutics
$70.20 /

-0.47 (-0.67%)

  • 07
    Aug
TCOM Trip.com Group
$33.60 /

-0.62 (-1.81%)

HZNP Horizon Therapeutics
$70.20 /

-0.47 (-0.67%)

SNDL Sundial Growers
$0.72 /

+0.347 (+93.28%)

TCOM Trip.com Group
$33.60 /

-0.62 (-1.81%)

HZNP Horizon Therapeutics
$70.20 /

-0.47 (-0.67%)

Downgrade
CoreLogic downgraded to Hold from Buy at Truist » 07:34
12/01/20
12/01
07:34
12/01/20
07:34
CLGX

CoreLogic

$77.51 /

-0.225 (-0.29%)

Truist analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
CLGX CoreLogic
$77.51 /

-0.225 (-0.29%)

CLGX CoreLogic
$77.51 /

-0.225 (-0.29%)

06:45 Today Truist
CoreLogic downgraded to Hold from Buy at Truist
10/28/20 Truist
CoreLogic could be sold for 'meaningfully more' than $80 per share, says Truist
09/22/20 Truist
CoreLogic increasingly likely to see other financial suitors, says Truist
07/24/20
Fly Intel: Top five analyst downgrades
CLGX CoreLogic
$77.51 /

-0.225 (-0.29%)

CLGX CoreLogic
$77.51 /

-0.225 (-0.29%)

Recommendations
Modest uptick in iPhone 12 Pro waits, Pro Max remains stable, says Credit Suisse » 07:34
12/01/20
12/01
07:34
12/01/20
07:34
AAPL

Apple

$119.06 /

+2.48 (+2.13%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$119.06 /

+2.48 (+2.13%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

11/30/20
Fly Intel: Top five analyst upgrades
11/30/20 Loop Capital
Apple upgraded to Buy from Hold at Loop Capital
11/30/20 Loop Capital
Apple upgraded to Buy from Hold at Loop Capital
11/25/20 Rosenblatt
Apple taking RF front-end in-house 'highly unlikely,' says Rosenblatt
AAPL Apple
$119.06 /

+2.48 (+2.13%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

AAPL Apple
$119.06 /

+2.48 (+2.13%)

Hot Stocks
BridgeBio, QED announce FDA acceptance of NDA for infigratinib » 07:34
12/01/20
12/01
07:34
12/01/20
07:34
BBIO

BridgeBio

$50.20 /

+1.08 (+2.20%)

BridgeBio Pharma and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BBIO BridgeBio
$50.20 /

+1.08 (+2.20%)

BBIO BridgeBio
$50.20 /

+1.08 (+2.20%)

11/18/20 BTIG
Eidos Therapeutics downgraded to Neutral from Buy at BTIG
11/05/20 Piper Sandler
BridgeBio price target raised to $60 from $50 at Piper Sandler
10/12/20 H.C. Wainwright
BridgeBio price target raised to $53 from $50 at H.C. Wainwright
10/07/20 Citi
Eidos Therapeutics downgraded to Neutral from Buy at Citi
BBIO BridgeBio
$50.20 /

+1.08 (+2.20%)

  • 29
    May
Hot Stocks
Scientific Games partners with Genius Sports Group » 07:33
12/01/20
12/01
07:33
12/01/20
07:33
SGMS

Scientific Games

$37.31 /

-1.95 (-4.97%)

Scientific Games partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SGMS Scientific Games
$37.31 /

-1.95 (-4.97%)

SGMS Scientific Games
$37.31 /

-1.95 (-4.97%)

11/16/20 Craig-Hallum
October NJ sports betting wagers set 3rd consecutive record, says Craig-Hallum
11/12/20 Deutsche Bank
Scientific Games price target raised to $26 from $16 at Deutsche Bank
11/05/20 Craig-Hallum
Scientific Games price target raised to $45 from $40 at Craig-Hallum
11/05/20 JPMorgan
Scientific Games price target raised to $30 from $18 at JPMorgan
SGMS Scientific Games
$37.31 /

-1.95 (-4.97%)

SGMS Scientific Games
$37.31 /

-1.95 (-4.97%)

SGMS Scientific Games
$37.31 /

-1.95 (-4.97%)

Hot Stocks
Frequency Therapeutics names Peter Pfreundschuh as new CFO » 07:33
12/01/20
12/01
07:33
12/01/20
07:33
FREQ

FREQ

/

+

Frequency Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FREQ FREQ
/

+

FREQ FREQ
/

+

07/13/20 Oppenheimer
Frequency Therapeutics initiated with an Outperform at Oppenheimer
05/18/20 JPMorgan
JPMorgan downgrades Frequency Therapeutics on unclear data timelines
05/18/20 JPMorgan
Frequency Therapeutics downgraded to Neutral from Overweight at JPMorgan
FREQ FREQ
/

+

FREQ FREQ
/

+

Hot Stocks
Athira Pharma initiates patient dosing for ACT-AD trial of ATH-1017 » 07:32
12/01/20
12/01
07:32
12/01/20
07:32
ATHA

Athira Pharma

$24.89 /

+0.82 (+3.41%)

Athira Pharma announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATHA Athira Pharma
$24.89 /

+0.82 (+3.41%)

ATHA Athira Pharma
$24.89 /

+0.82 (+3.41%)

10/13/20 Jefferies
Athira Pharma initiated with a Buy at Jefferies
10/13/20 JMP Securities
Athira Pharma initiated with an Outperform at JMP Securities
10/13/20 Stifel
Athira Pharma initiated with a Buy at Stifel
10/13/20 Goldman Sachs
Athira Pharma initiated with a Buy at Goldman Sachs
ATHA Athira Pharma
$24.89 /

+0.82 (+3.41%)

  • 18
    Sep
Recommendations
Zoom Video price target raised to $340 from $315 at Credit Suisse » 07:32
12/01/20
12/01
07:32
12/01/20
07:32
ZM

Zoom Video

$479.28 /

+7.98 (+1.69%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

07:12 Today William Blair
Zoom Video revenue lower than buy-side expectations, says William Blair
07:06 Today Stifel
Zoom Video price target raised to $450 from $400 at Stifel
07:05 Today Goldman Sachs
Zoom Video price target raised to $460 from $402 at Goldman Sachs
06:09 Today Piper Sandler
Zoom Video shares lower on high investor expectations, says Piper Sandler
ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

ZM Zoom Video
$479.28 /

+7.98 (+1.69%)

Hot Stocks
APi Group announces up to $100M share repurchase program » 07:31
12/01/20
12/01
07:31
12/01/20
07:31
APG

APi Group

$15.50 /

-0.2 (-1.27%)

APi Group announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APG APi Group
$15.50 /

-0.2 (-1.27%)

APG APi Group
$15.50 /

-0.2 (-1.27%)

09/22/20 Barclays
APi Group initiated with an Overweight at Barclays
08/17/20 UBS
APi Group price target raised to $20 from $15 at UBS
06/24/20 Baird
APi Group initiated with an Outperform at Baird
06/23/20 Baird
APi Group initiated with an Outperform at Baird
APG APi Group
$15.50 /

-0.2 (-1.27%)

Hot Stocks
Moleculin Biotech: FDA approves Rare Pediatric Disease designations for WP1066 » 07:31
12/01/20
12/01
07:31
12/01/20
07:31
MBRX

Moleculin Biotech

$0.78 /

+0.0018 (+0.23%)

Moleculin Biotech…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MBRX Moleculin Biotech
$0.78 /

+0.0018 (+0.23%)

MBRX Moleculin Biotech
$0.78 /

+0.0018 (+0.23%)

04/08/20 Roth Capital
Moleculin can expedite COVID candidate amid less restrictions, says Roth Capital
MBRX Moleculin Biotech
$0.78 /

+0.0018 (+0.23%)

Hot Stocks
Aeglea receives FDA Rare Pediatric Disease Designation for ACN00177 » 07:31
12/01/20
12/01
07:31
12/01/20
07:31
AGLE

Aeglea BioTherapeutics

$8.53 /

-0.12 (-1.39%)

Aeglea BioTherapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGLE Aeglea BioTherapeutics
$8.53 /

-0.12 (-1.39%)

AGLE Aeglea BioTherapeutics
$8.53 /

-0.12 (-1.39%)

08/10/20 Piper Sandler
Piper Sandler backs Overweight rating on Aeglea BioTherapeutics after Q2 results
05/04/20
Fly Intel: Top five analyst initiations
05/04/20 Piper Sandler
Aeglea BioTherapeutics initiated with an Overweight at Piper Sandler
04/30/20 H.C. Wainwright
Aeglea BioTherapeutics price target lowered to $18 from $24 at H.C. Wainwright
AGLE Aeglea BioTherapeutics
$8.53 /

-0.12 (-1.39%)

  • 28
    Apr
Recommendations
Voya Financial price target raised to $78 from $66 at Credit Suisse » 07:31
12/01/20
12/01
07:31
12/01/20
07:31
VOYA

Voya Financial

$57.65 /

-1.57 (-2.65%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VOYA Voya Financial
$57.65 /

-1.57 (-2.65%)

VOYA Voya Financial
$57.65 /

-1.57 (-2.65%)

11/19/20 Piper Sandler
Voya Financial price target raised to $65 from $57 at Piper Sandler
10/23/20 Piper Sandler
Colorado commissioner hearing a 'distinct positive' for Voya, says Piper Sandler
10/12/20 Gordon Haskett
Voya Financial CEO 'fits the profile of a seller,' says Gordon Haskett
10/01/20 BofA
Voya Financial reinstated with a Buy at BofA
VOYA Voya Financial
$57.65 /

-1.57 (-2.65%)

Recommendations
Texas Roadhouse butcher shop launch looks like 'smart move,' says Stephens » 07:31
12/01/20
12/01
07:31
12/01/20
07:31
TXRH

Texas Roadhouse

$75.75 /

+0.4801 (+0.64%)

Stephens analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TXRH Texas Roadhouse
$75.75 /

+0.4801 (+0.64%)

TXRH Texas Roadhouse
$75.75 /

+0.4801 (+0.64%)

11/23/20 Baird
Texas Roadhouse upgraded to Outperform from Neutral at Baird
11/23/20 Baird
Texas Roadhouse upgraded to Outperform from Neutral at Baird
11/13/20 Wedbush
Texas Roadhouse price target raised to $90 from $82 at Wedbush
11/02/20 Deutsche Bank
Texas Roadhouse price target raised to $68 from $58 at Deutsche Bank
TXRH Texas Roadhouse
$75.75 /

+0.4801 (+0.64%)

TXRH Texas Roadhouse
$75.75 /

+0.4801 (+0.64%)

Hot Stocks
Eve & Co launches cannabis-infused bath bombs in Ontario » 07:30
12/01/20
12/01
07:30
12/01/20
07:30
EEVVF

Eve & Co

$0.00 /

+ (+0.00%)

Eve & Co Incorporated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EEVVF Eve & Co
$0.00 /

+ (+0.00%)

Options
Unusual put flow in option market yesterday » 07:30
12/01/20
12/01
07:30
12/01/20
07:30
KSS

Kohl's

$32.19 /

-1.41 (-4.20%)

, CMCSA

Comcast

$50.24 /

-1.52 (-2.94%)

Notable put activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KSS Kohl's
$32.19 /

-1.41 (-4.20%)

CMCSA Comcast
$50.24 /

-1.52 (-2.94%)

KSS Kohl's
$32.19 /

-1.41 (-4.20%)

11/19/20 Morgan Stanley
Kohl's price target raised to $27 from $15 at Morgan Stanley
11/18/20 Credit Suisse
Kohl's price target raised to $30 from $23 at Credit Suisse
11/18/20 Deutsche Bank
Kohl's price target raised to $28 from $19 at Deutsche Bank
11/18/20 Citi
Kohl's price target raised to $33 from $21 at Citi
CMCSA Comcast
$50.24 /

-1.52 (-2.94%)

11/25/20 TD Securities
Comcast downgraded to Hold after recent rally at TD Securities
11/25/20 TD Securities
TD Securities downgrades Altice USA to Hold, raises price target to $40
11/25/20 TD Securities
Comcast downgraded to Hold from Buy at TD Securities
11/23/20 Stifel
Dycom price target raised to $90 from $69 at Stifel
KSS Kohl's
$32.19 /

-1.41 (-4.20%)

CMCSA Comcast
$50.24 /

-1.52 (-2.94%)

KSS Kohl's
$32.19 /

-1.41 (-4.20%)

CMCSA Comcast
$50.24 /

-1.52 (-2.94%)

KSS Kohl's
$32.19 /

-1.41 (-4.20%)

CMCSA Comcast
$50.24 /

-1.52 (-2.94%)

KSS Kohl's
$32.19 /

-1.41 (-4.20%)

CMCSA Comcast
$50.24 /

-1.52 (-2.94%)

Downgrade
IHS Markit downgraded to Hold from Buy at Truist » 07:28
12/01/20
12/01
07:28
12/01/20
07:28
INFO

IHS Markit

$99.37 /

+6.85 (+7.40%)

, SPGI

S&P Global

$351.89 /

+10.84 (+3.18%)

Truist analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
INFO IHS Markit
$99.37 /

+6.85 (+7.40%)

SPGI S&P Global
$351.89 /

+10.84 (+3.18%)

INFO IHS Markit
$99.37 /

+6.85 (+7.40%)

06:43 Today Truist
IHS Markit downgraded to Hold from Buy at Truist
06:36 Today RBC Capital
IHS Markit downgraded to Sector Perform from Outperform at RBC Capital
11/30/20 Oppenheimer
S&P Global, IHS Markit would benefit shareholders, says Oppenheimer
09/30/20 Truist
IHS Markit price target raised to $90 from $87 at Truist
SPGI S&P Global
$351.89 /

+10.84 (+3.18%)

06:36 Today RBC Capital
IHS Markit downgraded to Sector Perform from Outperform at RBC Capital
11/30/20
Fly Intel: Top five analyst initiations
11/30/20 Oppenheimer
S&P Global, IHS Markit would benefit shareholders, says Oppenheimer
11/30/20 Deutsche Bank
S&P Global initiated with a Buy at Deutsche Bank
INFO IHS Markit
$99.37 /

+6.85 (+7.40%)

SPGI S&P Global
$351.89 /

+10.84 (+3.18%)

INFO IHS Markit
$99.37 /

+6.85 (+7.40%)

SPGI S&P Global
$351.89 /

+10.84 (+3.18%)

INFO IHS Markit
$99.37 /

+6.85 (+7.40%)

SPGI S&P Global
$351.89 /

+10.84 (+3.18%)

SPGI S&P Global
$351.89 /

+10.84 (+3.18%)

Hot Stocks
Goodfood Market announces C$46M syndicated bank financing » 07:28
12/01/20
12/01
07:28
12/01/20
07:28
GDDFF

Goodfood Market

$0.00 /

+ (+0.00%)

Goodfood Market announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDDFF Goodfood Market
$0.00 /

+ (+0.00%)

GDDFF Goodfood Market
$0.00 /

+ (+0.00%)

11/12/20 Raymond James
Goodfood Market price target raised to C$12.50 from C$9.15 at Raymond James
11/12/20 Stifel
Goodfood Market price target raised to C$14 from C$12 at Stifel
11/12/20 National Bank
Goodfood Market price target raised to C$11 from C$10.50 at National Bank
11/09/20 Stifel
Goodfood Market price target raised to C$12 from C$10 at Stifel
Upgrade
Credit Suisse upgrades Lincoln National to Outperform with $56 target » 07:28
12/01/20
12/01
07:28
12/01/20
07:28
LNC

Lincoln National

$47.23 /

-1.92 (-3.91%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LNC Lincoln National
$47.23 /

-1.92 (-3.91%)

LNC Lincoln National
$47.23 /

-1.92 (-3.91%)

07:09 Today Credit Suisse
Lincoln National upgraded to Outperform from Neutral at Credit Suisse
11/17/20 Barclays
Lincoln National initiated with an Equal Weight at Barclays
10/23/20 Citi
Citi opens '30-day positive catalyst watch' on Lincoln National
07/16/20 Credit Suisse
Lincoln National price target lowered to $41 from $52 at Credit Suisse
LNC Lincoln National
$47.23 /

-1.92 (-3.91%)

LNC Lincoln National
$47.23 /

-1.92 (-3.91%)

Hot Stocks
CareDx announces publication on AlloSure in pediatric patients » 07:26
12/01/20
12/01
07:26
12/01/20
07:26
CDNA

CareDx

$31.00 /

+17 (+7.00%)

CareDx announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDNA CareDx
$31.00 /

+17 (+7.00%)

CDNA CareDx
$31.00 /

+17 (+7.00%)

11/17/20 Piper Sandler
CareDx reimbursement well above expectations, says Piper Sandler
10/30/20 Raymond James
CareDx price target raised to $62 from $42 at Raymond James
10/30/20 H.C. Wainwright
CareDx price target raised to $55 from $47 at H.C. Wainwright
10/08/20 BTIG
CareDx price target raised to $55 from $45 at BTIG
CDNA CareDx
$31.00 /

+17 (+7.00%)

  • 11
    Jun
CDNA CareDx
$31.00 /

+17 (+7.00%)

Recommendations
Adient price target raised to $36 from $29 at Credit Suisse » 07:26
12/01/20
12/01
07:26
12/01/20
07:26
ADNT

Adient

$31.20 /

-2.76 (-8.13%)

Credit Suisse analyst Dan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ADNT Adient
$31.20 /

-2.76 (-8.13%)

ADNT Adient
$31.20 /

-2.76 (-8.13%)

07:19 Today KeyBanc
Adient price target raised to $36 from $31 at KeyBanc
06:43 Today RBC Capital
Adient price target raised to $38 from $24 at RBC Capital
11/17/20 BofA
Adient, Aptiv get double downgrades as BofA reshuffles auto industry ratings
11/17/20 BofA
Adient downgraded to Underperform from Buy at BofA
ADNT Adient
$31.20 /

-2.76 (-8.13%)

Hot Stocks
Semtech, CNIguard, Senet collaborate for natural gas monitoring solutions » 07:25
12/01/20
12/01
07:25
12/01/20
07:25
SMTC

Semtech

$67.42 /

-1.4 (-2.03%)

Senet announced it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SMTC Semtech
$67.42 /

-1.4 (-2.03%)

SMTC Semtech
$67.42 /

-1.4 (-2.03%)

11/30/20 B. Riley Securities
Semtech price target raised to $83 from $72 at B. Riley Securities
11/25/20 Oppenheimer
Semtech price target raised to $75 from $65 at Oppenheimer
08/27/20 B. Riley FBR
Semtech price target raised to $72 from $65 at B. Riley FBR
08/27/20 Wells Fargo
Semtech price target raised to $67 from $57 at Wells Fargo
SMTC Semtech
$67.42 /

-1.4 (-2.03%)

SMTC Semtech
$67.42 /

-1.4 (-2.03%)

Recommendations
Abercrombie & Fitch price target raised to $14 from $10 at Morgan Stanley » 07:24
12/01/20
12/01
07:24
12/01/20
07:24
ANF

Abercrombie & Fitch

$20.75 /

-1.9 (-8.39%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANF Abercrombie & Fitch
$20.75 /

-1.9 (-8.39%)

ANF Abercrombie & Fitch
$20.75 /

-1.9 (-8.39%)

11/25/20 Baird
Abercrombie & Fitch price target raised to $24 from $14 at Baird
11/25/20 B. Riley Securities
Abercrombie & Fitch price target raised to $27 from $22 at B. Riley Securities
11/25/20 RBC Capital
Abercrombie & Fitch price target raised to $25 from $14 at RBC Capital
11/25/20 Citi
Abercrombie & Fitch price target raised to $28 from $20 at Citi
ANF Abercrombie & Fitch
$20.75 /

-1.9 (-8.39%)

ANF Abercrombie & Fitch
$20.75 /

-1.9 (-8.39%)

Upgrade
Verisk Analytics upgraded to Buy from Hold at Truist » 07:24
12/01/20
12/01
07:24
12/01/20
07:24
VRSK

Verisk Analytics

$198.16 /

+0.12 (+0.06%)

Truist analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRSK Verisk Analytics
$198.16 /

+0.12 (+0.06%)

VRSK Verisk Analytics
$198.16 /

+0.12 (+0.06%)

06:44 Today Truist
Verisk Analytics upgraded to Buy from Hold at Truist
11/09/20 BMO Capital
Verisk Analytics price target raised to $196 from $181 at BMO Capital
11/06/20 Barclays
Verisk Analytics price target raised to $220 from $210 at Barclays
11/05/20 Deutsche Bank
Verisk Analytics price target raised to $192 from $183 at Deutsche Bank
VRSK Verisk Analytics
$198.16 /

+0.12 (+0.06%)

Hot Stocks
BioCardia announces publication of study using Helix System » 07:23
12/01/20
12/01
07:23
12/01/20
07:23
BCDA

BioCardia

$2.35 /

-0.01 (-0.42%)

BioCardia announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BCDA BioCardia
$2.35 /

-0.01 (-0.42%)

BCDA BioCardia
$2.35 /

-0.01 (-0.42%)

09/21/20
Fly Intel: Top five analyst initiations
09/21/20 Alliance Global Partners
BioCardia initiated with a Buy at Alliance Global Partners
BCDA BioCardia
$2.35 /

-0.01 (-0.42%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.